Detalhe da pesquisa
1.
Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms.
Cancer Gene Ther
; 28(1-2): 5-17, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32457487
2.
Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas.
Nat Commun
; 12(1): 2582, 2021 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33976133
3.
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells.
Cancer Discov
; 11(8): 2050-2071, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33707234
4.
Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells.
J Exp Med
; 217(7)2020 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32374402
5.
Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity.
J Exp Med
; 215(10): 2617-2635, 2018 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30185635
6.
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity.
Science
; 359(6383): 1537-1542, 2018 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29599246
7.
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.
Science
; 359(6377): 770-775, 2018 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-29301958
8.
Correction: Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells.
J Exp Med
; 217(7)2020 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32441763